Caricamento...
Testosterone suppression in the treatment of recurrent or metastatic prostate cancer — A Canadian consensus statement
Testosterone suppression, achieved through orchiectomy or medically induced androgen-deprivation therapy (ADT), is a standard treatment for men with recurrent and metastatic prostate cancer. Current assay methods demonstrate the capacity for testosterone suppression to <0.7 nmol/l, and clinical d...
Salvato in:
| Pubblicato in: | Can Urol Assoc J |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Canadian Medical Association
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5937399/ https://ncbi.nlm.nih.gov/pubmed/29680011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.5116 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|